Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - oxpentifylline -

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pentoxifylline 400mg - modified release tablet - 400 mg - active: pentoxifylline 400mg excipient: acacia erythrosine hyetellose macrogol 6000 magnesium stearate povidone purified talc   sucrose titanium dioxide

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

clinect nz pty limited - pentoxifylline 400mg;  ;   - modified release tablet - 400 mg - active: pentoxifylline 400mg     excipient: erythrosine hyetellose hypromellose macrogol 8000 magnesium stearate povidone purified talc   purified water   titanium dioxide - the treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - pentoxifylline, quantity: 400 mg - tablet, modified release - excipient ingredients: povidone; hyetellose; titanium dioxide; hypromellose; erythrosine; purified talc; macrogol 8000; magnesium stearate - treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. trental 400 can thus improve function and symptoms but is not intended to replace more definitive therapy, such as vascular surgery, or removal of arterial obstructions when treating peripheral vascular disease.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - doxycycline monohydrate -

Canada - Tiếng Anh - Health Canada

sanofi-aventis canada inc - pentoxifylline - tablet (extended-release) - 400mg - pentoxifylline 400mg - hemorrheologic agents

Canada - Tiếng Anh - Health Canada

ratiopharm inc division of teva canada limited - pentoxifylline - tablet (extended-release) - 400mg - pentoxifylline 400mg - hemorrheologic agents

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

bryant ranch prepack - pentoxifylline (unii: sd6qct3tsu) (pentoxifylline - unii:sd6qct3tsu) - pentoxifylline 400 mg - pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. pentoxifylline can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease. pentoxifylline should not be used in patients with recent cerebral and/or retinal hemorrhage or in patients who have previously exhibited intolerance to this product or methylxanthines such as caffeine, theophylline, and theobromine.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

teva pharmaceuticals usa inc - pentoxifylline (unii: sd6qct3tsu) (pentoxifylline - unii:sd6qct3tsu) - pentoxifylline 400 mg